EberhardE.NieschlagEberhardE., SusanS.NieschlagSusanS., ENDOCRINE HISTORY: The history of discovery, synthesis and development of testosterone for clinical use, „European Journal of Endocrinology”, 180 (6), 2019, R201–R212, DOI:10.1530/EJE-19-0071(ang.).
Peter J.P.J.SnyderPeter J.P.J. i inni, Lessons From the Testosterone Trials, „Endocrine Reviews”, 39 (3), 2018, s. 369–386, DOI:10.1210/er.2017-00234, PMID:29522088(ang.).
EricE.BachmanEricE. i inni, Testosterone Induces Erythrocytosis via Increased Erythropoietin and Suppressed Hepcidin: Evidence for a New Erythropoietin/Hemoglobin Set Point, „The Journals of Gerontology: Series A”, 69 (6), 2014, s. 725–735, DOI:10.1093/gerona/glt154, PMID:24158761(ang.).
S.N.S.N.GenioleS.N.S.N. i inni, Is testosterone linked to human aggression? A meta-analytic examination of the relationship between baseline, dynamic, and manipulated testosterone on human aggression, „Hormones and Behavior”, 123, 2020, s. 104644, DOI:10.1016/j.yhbeh.2019.104644, PMID:31785281(ang.).
Susan R.S.R.DavisSusan R.S.R. i inni, Global Consensus Position Statement on the Use of Testosterone Therapy for Women, „The Journal of Clinical Endocrinology & Metabolism”, 104 (10), 2019, s. 4660–4666, DOI:10.1210/jc.2019-01603, PMID:31498871(ang.).
ShalenderS.BhasinShalenderS. i inni, Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline, „The Journal of Clinical Endocrinology & Metabolism”, 103 (5), 2018, s. 1715–1744, DOI:10.1210/jc.2018-00229, PMID:29562364(ang.).
GiovanniG.CoronaGiovanniG. i inni, EAU Guidelines on Sexual and Reproductive Health: A Summary of the 2026 Recommendations for Measurement and Biochemical Confirmation of Hypogonadism, „European Urology Focus”, 2026, DOI:10.1016/j.euf.2026.04.015, PMID:42177105(ang.).
Helena J.H.J.TeedeHelena J.H.J. i inni, Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome, „The Journal of Clinical Endocrinology & Metabolism”, 108 (10), 2023, s. 2447–2469, DOI:10.1210/clinem/dgad463, PMID:37580314(ang.).
Sharon J.S.J.ParishSharon J.S.J. i inni, International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women, „Journal of Women's Health”, 30 (4), 2021, s. 474–491, DOI:10.1089/jwh.2021.29037, PMID:33797277(ang.).
Wylie C.W.C.HembreeWylie C.W.C. i inni, Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline, „The Journal of Clinical Endocrinology & Metabolism”, 102 (11), 2017, s. 3869–3903, DOI:10.1210/jc.2017-01658, PMID:28945902(ang.).
ShalenderS.BhasinShalenderS. i inni, Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial, „JAMA Network Open”, 6 (12), 2023, e2348692, DOI:10.1001/jamanetworkopen.2023.48692, PMID:38150256(ang.).
Peter J.P.J.SnyderPeter J.P.J. i inni, Lessons From the Testosterone Trials, „Endocrine Reviews”, 39 (3), 2018, s. 369–386, DOI:10.1210/er.2017-00234, PMID:29522088(ang.).
EricE.BachmanEricE. i inni, Testosterone Induces Erythrocytosis via Increased Erythropoietin and Suppressed Hepcidin: Evidence for a New Erythropoietin/Hemoglobin Set Point, „The Journals of Gerontology: Series A”, 69 (6), 2014, s. 725–735, DOI:10.1093/gerona/glt154, PMID:24158761(ang.).
S.N.S.N.GenioleS.N.S.N. i inni, Is testosterone linked to human aggression? A meta-analytic examination of the relationship between baseline, dynamic, and manipulated testosterone on human aggression, „Hormones and Behavior”, 123, 2020, s. 104644, DOI:10.1016/j.yhbeh.2019.104644, PMID:31785281(ang.).
Susan R.S.R.DavisSusan R.S.R. i inni, Global Consensus Position Statement on the Use of Testosterone Therapy for Women, „The Journal of Clinical Endocrinology & Metabolism”, 104 (10), 2019, s. 4660–4666, DOI:10.1210/jc.2019-01603, PMID:31498871(ang.).
ShalenderS.BhasinShalenderS. i inni, Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline, „The Journal of Clinical Endocrinology & Metabolism”, 103 (5), 2018, s. 1715–1744, DOI:10.1210/jc.2018-00229, PMID:29562364(ang.).
GiovanniG.CoronaGiovanniG. i inni, EAU Guidelines on Sexual and Reproductive Health: A Summary of the 2026 Recommendations for Measurement and Biochemical Confirmation of Hypogonadism, „European Urology Focus”, 2026, DOI:10.1016/j.euf.2026.04.015, PMID:42177105(ang.).
Helena J.H.J.TeedeHelena J.H.J. i inni, Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome, „The Journal of Clinical Endocrinology & Metabolism”, 108 (10), 2023, s. 2447–2469, DOI:10.1210/clinem/dgad463, PMID:37580314(ang.).
Sharon J.S.J.ParishSharon J.S.J. i inni, International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women, „Journal of Women's Health”, 30 (4), 2021, s. 474–491, DOI:10.1089/jwh.2021.29037, PMID:33797277(ang.).
Wylie C.W.C.HembreeWylie C.W.C. i inni, Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline, „The Journal of Clinical Endocrinology & Metabolism”, 102 (11), 2017, s. 3869–3903, DOI:10.1210/jc.2017-01658, PMID:28945902(ang.).
ShalenderS.BhasinShalenderS. i inni, Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial, „JAMA Network Open”, 6 (12), 2023, e2348692, DOI:10.1001/jamanetworkopen.2023.48692, PMID:38150256(ang.).
pubchem.ncbi.nlm.nih.gov
Testosterone (CID 6013) [online], PubChem, National Center for Biotechnology Information [dostęp 2026-10-24](ang.).